FDA
WASHINGTON, D.C. — The U.S. Food and Drug Administration's (FDA) Human Foods Program (HFP) released its updated 2026 guidance agenda, including possible new topics for guidance documents or revisions to existing guidance documents that HFP is considering. The topics on the agenda are a priority for the agency’s Human Foods Program to complete during 2026, FDA said. New topics include:
- Labeling Caffeine Content in Foods and Beverages; Draft Guidance for Industry
- Questions and Answers Regarding Use of the “Healthy” Claim
- Necessity of the Use of Food Product Categories in Food Facility Registrations and Updates to Food Product Categories: Guidance for Industry
The complete list can be found at Foods Program Guidance Under Development. The agency said it also may issue additional guidance that is not on the list.
Guidance documents represent the FDA’s current thinking on a specific topic, and the information in them can help stakeholders, according to the agency. The agency said guidance documents do not impose legally enforceable requirements. Public comments on the list of human food and cosmetic guidance topics, including suggestions for alternatives or recommendations on the topics the FDA is considering, can be submitted to www.regulations.gov, using Docket FDA-2022-D-2088.
Latest from Quality Assurance & Food Safety
- FSIS to Expand Animal Drug Residue Testing Capabilities
- FDA Advises Food Facilities to Protect Registration Information
- FDA Says Cyclospora Lettuce Test Was False Positive
- Taylor Farms Removes Iceberg Lettuce Sourced from Mexico Amid Cyclospora Outbreak
- FDA, CDC Tie Multistate Cyclospora Outbreak to Taco Bell Lettuce
- BCG and CGF Release New Report on AI Usage by CPG and Retail Companies
- IntelliAM AI Launches Industrial Intelligence Platform
- QA Virtual Conference to Explore Pest Control Strategies for Food Facilities
